Beta
21 CFR § 524.1610
21 CFR § 524.1610 — § 524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.
Analyze this law with AI§ 524.1610 Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
(a) Specifications. Each gram of suspension contains 10 milligrams (mg) orbifloxacin, mometasone furoate monohydrate equivalent to 1 mg mometasone furoate, and 1 mg posaconazole.
(b) Sponsor. See No. 000061 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs —(1) Amount. For dogs weighing less than 30 lbs. instill 4 drops once daily into the ear canal. For dogs weighing 30 lbs. or more, instill 8 drops into the ear canal. Therapy should continue for 7 consecutive days.
(2) Indications for use. For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria (coagulase-positive staphylococci, Pseudomonas aeruginosa , and Enterococcus faecalis ).
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[75 FR 16346, Apr. 1, 2010]
